Incidence and Predictors Of Prolonged Dual Antiplatelet Therapy Among Patients After Percutaneous Coronary Intervention

被引：0
|
作者：
Zheng, Bo [1 ]
Jiang, Jie [1 ]
Zhang, Yan [1 ]
Yu, Ronghui [1 ]
Huo, Yong [1 ]
Hong, Tao [1 ]
机构：
[1] Peking Univ, Hosp 1, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2015.06.518
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW26-e0268
引用
收藏
页码：C134 / C135
页数：2
相关论文
共 50 条
  • [1] Incidence Predictors Of Discontinued Dual Antiplatelet Therapy Among Patients After Percutaneous Coronary Intervention
    Jiang, Jie
    Zheng, Bo
    Zhang, Yan
    Yu, Ronghui
    Huo, Yong
    Hong, Tao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C135 - C135
  • [2] Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
    Han, Jialun
    Zhang, Yi
    Shi, Xiujin
    Lin, Baidi
    Zhang, Yunnan
    Zhang, Ru
    Wang, Yifan
    Yan, Jialin
    Lin, Yang
    GLOBAL HEART, 2023, 18 (01)
  • [3] Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention
    Kari L. Olson
    Thomas Delate
    Samuel G. Johnson
    Erika Dawn Wilson
    Daniel M. Witt
    Journal of Thrombosis and Thrombolysis, 2010, 29 : 316 - 321
  • [4] Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention
    Olson, Kari L.
    Delate, Thomas
    Johnson, Samuel G.
    Wilson, Erika Dawn
    Witt, Daniel M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 29 (03) : 316 - 321
  • [5] Impact of Prolonged Dual Antiplatelet Therapy After Bifurcation Percutaneous Coronary Intervention in Patients with High Ischemic Risk
    Khelimskii, Dmitrii
    Bessonov, Ivan
    Sapozhnikov, Stanislav
    Badoyan, Aram
    Baranov, Aleksey
    Mamurjon, Mahmudov
    Manukian, Serezha
    Utegenov, Ruslan
    Krestyaninov, Oleg
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, : 577 - 588
  • [6] Dual antiplatelet therapy after percutaneous coronary intervention: Personalize the duration
    Howard, Travis M.
    Khot, Umesh N.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (06) : 325 - 332
  • [7] EFFICACY OF RECTAL DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
    Nowrozi, Arian
    Kim, Michael
    Gavrilos, George
    Hadley, Sydney
    Kabbany, Mohammad
    CRITICAL CARE MEDICINE, 2024, 52
  • [8] Antiplatelet Therapy for Patients with Hemophilia after Percutaneous Coronary Intervention
    Xie, Peter
    Malik, Devin
    Kuriakose, Philip
    BLOOD, 2018, 132
  • [9] Incidence and patterns of dual antiplatelet therapy cessation among patients with peripheral arterial disease after percutaneous coronary intervention: insights the PARIS registry
    Sorrentino, S.
    Snyder, C.
    Baber, U.
    Sartori, S.
    Cohen, D. J.
    Cono, A.
    Gibson, M.
    Krucoff, M. W.
    Moliterno, D. J.
    Chieffo, A.
    Kini, A.
    Witzenbichler, B.
    Steng, F. G.
    Pocock, S.
    Mehran, R.
    EUROPEAN HEART JOURNAL, 2017, 38 : 81 - 82
  • [10] Clinical benefits of prolonged dual antiplatelet therapy following complex percutaneous coronary intervention
    Subhaharan, Deloshaan
    Mridha, Naim
    Singh, Kuljit
    CORONARY ARTERY DISEASE, 2020, 31 (03) : 273 - 278
12345